UTMD Utah Medical Products, Inc. Accounting Capitalization

UTMD (utahmed.com) - company brandmark

Utah Medical Products (UTMD) relies on deep vertical integration, manufacturing complex devices in-house and purchasing only raw plastic. The secure delivery of sterile gynecological instruments to clinics is ensured by streamlined logistics and compact packaging. The share price history, which stands at 0.12, confirms the success of ultra-conservative management that eliminates debt and strictly controls operating expenses to maintain high profitability.

UTMD Utah Medical Products, Inc. Book Capitalization (07/04/2022 - 10/28/2026)

Utah Medical Products, Inc. (UTMD) - metric breakdowns and financial figures

- price and consensus price forecast:
Stock Quotes Utah Med|UTMD - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Utah Medical Products Inc.|UTMD - Total Company Value
- book capitalization data:
Accounting Value per Share Utah Medical Products|UTMD - Book Capitalization|Market-to-Book Ratio utahmed.com|UTMD - Company Total Assets
- debt and liquidity data:
Debt to Equity Ratio Utah Medical Products|UTMD - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Utah Medical Products Inc.|UTMD - Company Aggregate Debts|Debt to Book Value Utah Medical Products Inc.|UTMD - Company Long-Term Debts|Company Short-Term Debts Utah Medical Products
Fundamental valuation:UTMD - Utah Med
Mass-produced product of Utah Medical

Book value capitalization reflects the actual value of the issuer's net capital, excluding market speculation. Investors compare this basis with quotes to identify whether an asset is undervalued or overheated. By analyzing the current volume of book capital, one can determine the investment's margin of safety. Growth in this metric confirms the strengthening of Utah Medical Products (UTMD) assets. Stable demand for specialized neonatology instruments ensures the sustainable development of the company's equity.

Competitor analysis for Utah Medical Products

ISRG - Company Net Assets|Book Capitalization Danaher Corp.|BDX (bd.com) - Accounting Capitalization|Company Book Value STE|Company Net Assets West Pharma|Baxter Corp - Book Capitalization|Total Stockholders' Equity Masimo Inc. (MASI)|STVN - Book Capitalization|Accounting Capitalization teleflex.com TFX|Book Capitalization MMSI (Merit Medical)|NVST - Book Valuation of Business|ICUI (ICU Medical Corp) - Book Capitalization|Sirona Dental Systems (XRAY) - Company Net Assets|LMAT (LeMaitre Vascular, Inc.) - Book Capitalization|Book Capitalization ATRC|Company Book Value STAAR Surgical (STAA)|Company Book Value Chromadex Corp NAGE|Company Net Assets ZimVie Dental|Accounting Value of Company AngioDynamics Inc. ANGO|Book Capitalization CERS (Cerus Corporation)|TKNO: Book Valuation of Business|Company Book Value Monogram Orthopedics|STSS (Sharps Technology) - Accounting Capitalization|INFU: Company Book Value|Book Valuation of Business KORU Medical Systems Inc. (KRMD)|Company Net Assets Nyxoah S.A.|Total Net Assets MBOT (microbotmedical.com)|Company Book Value Pro-Dex|ZTEK - Accounting Value of Company|Elutia Corp - Company Net Assets|MLSS: Book Capitalization|NXGL (NEXGEL, Inc.) - Company Book Value|Retractable Technologies, Inc. (RVP) - Company Net Assets|Book Capitalization HBIO (Harvard Bioscience, Inc.)|Total Stockholders' Equity FEMY|Company Book Value MeihuaMed MHUA|Accounting Capitalization predictive-oncology.com POAI|Company Net Assets Callan JMB (CJMB)|atrioncorp.com - Total Net Assets|Company Book Value NURO (NeuroMetrix)